Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Surface Oncology
Biotech
Surface warns bankruptcy possible if shareholders reject merger
Surface told investors that outlays triggered by the deal have shrunk its cash runway and will leave it needing funding fast if the deal collapses.
Nick Paul Taylor
Aug 2, 2023 10:00am
Coherus scratches the Surface with $65M buy
Jun 16, 2023 10:45am
Surface Oncology cuts 20% workforce, drops anti-tumor antibody
Nov 2, 2022 8:25am
GSK puts up to $815M on the table for Surface Oncology drug
Dec 17, 2020 8:58am
Surface’s Biniszkiewicz, Chappel join MPM as executive partners
Sep 13, 2018 10:51am
Surface Oncology, Mereo gun for $156M Nasdaq IPOs
Mar 26, 2018 8:13am
